How and when should oxygen therapy be initiated, managed, and weaned in infants with acute bronchiolitis?

Oxygen Therapy in Acute Bronchiolitis: Initiation, Management, and Weaning

When to Initiate Oxygen Therapy

Supplemental oxygen should be withheld unless oxyhemoglobin saturation falls below 90% in infants with bronchiolitis. 1

• The American Academy of Pediatrics (AAP) guideline explicitly states that clinicians may choose not to administer supplemental oxygen if SpO2 exceeds 90%, though this is based on low-quality evidence and reasoning from first principles 1
• A large randomized equivalence trial (BIDS) demonstrated that managing infants to an oxygen saturation target of ≥90% is as safe and clinically effective as a target of ≥94%, with equivalent time to cough resolution (15 days median in both groups) and no significant differences in serious adverse events 2
• More recent AARC guidelines recommend targeting SpO2 of 90-97% specifically for infants and children with bronchiolitis 3

Key caveat: This permissive hypoxemia approach (90% threshold) applies only to previously healthy infants with bronchiolitis, not those with underlying cardiac disease, chronic lung disease, or immunodeficiency 1

How to Deliver Oxygen Therapy

High-flow nasal cannula (HFNC) therapy should be used preferentially over low-flow oxygen for infants with moderate to severe bronchiolitis requiring supplemental oxygen. 3, 4

High-Flow vs. Low-Flow Oxygen:

• HFNC (2-3 L/kg/min up to 60 L/min) reduces treatment escalation by 45% compared to standard low-flow oxygen (RR 0.55,95% CI 0.39-0.79) 5
• A large multicenter RCT showed escalation of care occurred in only 12% of infants receiving HFNC versus 23% receiving standard oxygen therapy (11% absolute risk reduction, P<0.001) 4
• HFNC modestly reduces length of hospital stay (mean difference -0.65 days) and duration of oxygen therapy (mean difference -0.59 days) 5
• HFNC improves respiratory rate and heart rate at multiple time points (1,4-6, and 24 hours) compared to baseline 5
• No significant difference in adverse events exists between HFNC and low-flow oxygen (RR 1.2,95% CI 0.38-3.74) 5

Delivery Device Considerations:

• Oxygen hoods or tents are not recommended over low-flow devices for consistent oxygen delivery 3
• Humidification with low-flow oxygen delivery is not recommended 3

Rescue Therapy:

• Among infants who fail standard oxygen therapy, 61% respond to HFNC rescue therapy 4

Monitoring During Oxygen Therapy

Continuous pulse oximetry monitoring is not necessary for stable children with bronchiolitis once they are maintaining adequate saturations on supplemental oxygen. 6

• Continuous monitoring has been identified as a low-value practice in stable patients not requiring oxygen adjustments 6
• Caregivers generally do not express concerns when monitoring is appropriately deimplemented with proper education 6

When to Wean and Discontinue Oxygen

Oxygen therapy should be weaned as tolerated to maintain SpO2 ≥90%, and infants can be safely discharged 4 hours after cessation of supplemental oxygen. 7

Weaning Protocol:

• Titrate oxygen flow downward as clinical status improves while maintaining SpO2 ≥90% 1, 2
• No specific weaning protocol is mandated by guidelines, but clinical improvement (decreased work of breathing, improved feeding, stable vital signs) should guide weaning 1

Post-Oxygen Observation Period:

• A retrospective cohort study of 884 infants demonstrated that discharge 4 hours after oxygen cessation is safe, with no increase in readmissions (0.6% vs 1.4%, P=0.317) or clinical deterioration events 7
• This approach reduced median time to discharge by 87 minutes and median length of stay by 6.7 hours without adverse outcomes 7
• Among 71 patients discharged within 4 hours of oxygen cessation, there were zero readmissions or clinical deterioration events 7

Common Pitfalls to Avoid

• Avoid targeting normoxic saturations (≥94%): This leads to prolonged hospitalization without clinical benefit, as demonstrated by the BIDS trial showing equivalence between 90% and 94% targets 2
• Do not routinely use medications: Albuterol, hypertonic saline, and epinephrine are deimplemented for routine use, though some evidence suggests selected patients may benefit from therapeutic trials in outpatient settings 8, 9
• Do not delay HFNC: Early initiation of HFNC in moderate-to-severe cases prevents treatment escalation more effectively than waiting for standard oxygen to fail 4
• Avoid unnecessary humidification: Low-flow oxygen does not require humidification 3